Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2003
11/13/2003WO2003032948A3 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
11/13/2003WO2003031593A3 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
11/13/2003WO2003028667A3 Semisolid topical hormonal compositions and methods for treatment
11/13/2003WO2003028657A9 Compositions for oral gene therapy and methods of using same
11/13/2003WO2003026588A3 Methods and apparatus for extrusion of vesicles at high pressure
11/13/2003WO2003022360A3 Thermotherapy via targeted delivery of nanoscale magnetic particles
11/13/2003WO2003018134A3 Bioadhesive compositions and methods for enhanced mucosal drug absorption
11/13/2003WO2003017921A3 A method to improve complexation efficacy and produce high-energy cyclodextrin-complexes
11/13/2003WO2003000227A3 A method for preparation of vesicles loaded with biological material and different uses thereof
11/13/2003WO2003000065A3 Tooth whitening chewing gum
11/13/2003WO2002069198A3 Hla ligand database utilizing predictive algorithms and methods of making and using same
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003WO2002019993A8 Granular preparations for oral administration
11/13/2003WO2002015965A8 Constant rate fluid delivery device with selectable flow rate and titratable bolus button
11/13/2003US20030212441 Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
11/13/2003US20030212416 Hydrogel adhesives with enhanced cohesiveness, and peel force for use on hair or fiber-populated surfaces
11/13/2003US20030212386 Sustained release of drug; fluid bladder; hermetic sealing; pressurization
11/13/2003US20030212379 Systems and methods for remotely controlling medication infusion and analyte monitoring
11/13/2003US20030212364 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
11/13/2003US20030212279 Anticholesterol agents
11/13/2003US20030212272 Vasodilation; hypotensive agents; cardiovascular disorders
11/13/2003US20030212249 Synthesis of cyclosporin analogs
11/13/2003US20030212179 Slurry containing multimetallic filler
11/13/2003US20030212148 Mixture of polyorthoester and excipients; sustained release
11/13/2003US20030212139 Methods, compositions, and kits for enhancing female sexual desire and responsiveness
11/13/2003US20030212128 Crystalline particles of escitalopram oxalate having a median particle size of >40 mu m; cystallization by gradually cooling the solution of dissolved escitalopram oxalate at a controlled cooling rate; adding crystals of escitalopram oxalate and holding; isolating particles
11/13/2003US20030212114 Stable emulsion compositions
11/13/2003US20030212112 Method for administering a phosphodiesterase 4 inhibitor
11/13/2003US20030212102 Novel solid dispersion compositions
11/13/2003US20030212099 Stabilized pharmacutical compositions comprising acid donors
11/13/2003US20030212090 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
11/13/2003US20030212075 Inhalation aerosol comprising tiotropium salt and propellant gas; respiratory system disorders
11/13/2003US20030212062 Morpholinone and morpholine derivatives and uses thereof
11/13/2003US20030212058 Side effect reduction; osteoporosis therapy
11/13/2003US20030212053 Nanoparticulate eplerenone compositions
11/13/2003US20030212046 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
11/13/2003US20030212040 Immobilized cell using polyglucosamine; encapsulating drug
11/13/2003US20030212031 Stable lipid-comprising durg delivery complexesand methods for their production
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212022 Injectable; mixture containing hydrophilic, biocompatibility polymer spherical particles, active material and transfection agent; anticancer agents
11/13/2003US20030212009 Isoflavone derivatives
11/13/2003US20030212004 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
11/13/2003US20030211997 Mimetic peptides for an epitope of apolipoprotein B-100, concatemers of the peptides, and modified peptides, and compositions comprising the same
11/13/2003US20030211995 Therapy for drug resistance bacteria
11/13/2003US20030211983 Pharmaceutical preparations comprising cyclosporin for oral administration
11/13/2003US20030211976 Antidiabetic agents
11/13/2003US20030211974 Sustained release of drug using biocompatible polymer
11/13/2003US20030211972 Systemic administration of a therapeutic preparation
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
11/13/2003US20030211966 Novel pharmacotherapeutic process and composition for central nervous system disorders
11/13/2003US20030211607 Antisense modulation of survivin expression
11/13/2003US20030211440 Methods and systems for concurrent tooth repositioning and substance delivery
11/13/2003US20030211259 Container for product integrity and identification
11/13/2003US20030211257 For food, drugs; printing design on hard capsules
11/13/2003US20030211229 Electrostatic application of powder material to solid dosage forms
11/13/2003US20030211180 Viricides, anticancer agents; side effect reduction
11/13/2003US20030211173 Lubrication composition
11/13/2003US20030211168 Spray drying solution of cellulose binder; controlling particle sizes
11/13/2003US20030211167 Aqueous solution of amylopectin starch and drugs; injectable
11/13/2003US20030211165 Anticancer agents; mixture of hydrophilic, crosslinked polymer and drugs
11/13/2003US20030211164 Method for preparing microparticles having a selected polymer molecular weight
11/13/2003US20030211162 Heating with carrier; mixtur eof fine and coarse particle sizes
11/13/2003US20030211161 Anhydrous mixture of polyalcohol and insulation gel; dysmenorrhea
11/13/2003US20030211160 Pharmaceutical compositions
11/13/2003US20030211159 Gaseous extraction of solvent
11/13/2003US20030211158 Microgel particles for the delivery of bioactive materials
11/13/2003US20030211157 Fineness particle sizes; therapy for drug abruse; sustained release; dispersed in biopolymer
11/13/2003US20030211156 Film-coated tablet for improved upper gastrointestinal tract safety
11/13/2003US20030211155 Stabilized pharmaceutical composition
11/13/2003US20030211154 Coating composition for facilitating controlled release
11/13/2003US20030211153 Somatotropin in biocompatible polymer matrix; aqueous solution administering by injection
11/13/2003US20030211152 Controlled release formulation for treating COPD
11/13/2003US20030211151 Dihydroxy open-acid and salts of HMG-Co-A reductase inhibitors
11/13/2003US20030211150 Immediate release tablet containing naproxen sodium
11/13/2003US20030211149 Extended release tablets comprising felodipine
11/13/2003US20030211148 Neutralization mixtures; spraying
11/13/2003US20030211147 Compressed core; multilayer enteric overcoatings; antisecretory, antiulcer agents
11/13/2003US20030211146 Dipping, molding capsules from starches
11/13/2003US20030211145 Antiinflammatory agents, analgesics, antiarthritic agents; liquid filled capsulaes
11/13/2003US20030211144 Water-insoluble drug delivery system
11/13/2003US20030211143 Emulsion and micellar formulations for the delivery of biologically active substances to cells
11/13/2003US20030211142 Liposome
11/13/2003US20030211140 Lipid encapsulating hydrophobic core; drugs; anesthetic
11/13/2003US20030211139 Synthetic vector for therapy
11/13/2003US20030211138 Reversable heat sensitive element; heat patch; skin disorders
11/13/2003US20030211136 Mixture of water soluble polymer, taste masking compound and drug
11/13/2003US20030211134 Topical glycopyrrolate product
11/13/2003US20030211127 Controlled dissolution crosslinked prote in crystals
11/13/2003US20030211123 Using citric acid esters or ethers
11/13/2003US20030211122 Mucosal microparticle conjugate vaccine
11/13/2003US20030211115 Adjuvant compositions for mucosal and injection delivered vaccines
11/13/2003US20030211089 Transgenic algae for delivering antigens to an animal
11/13/2003US20030211083 Injectable microspheres for tissue construction
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003US20030211077 Stimulanting hematopoiesis
11/13/2003US20030211071 Containing crosslinked polymer and active material
11/13/2003US20030211070 Mixture of wax and hydrophobic oil; setting hair
11/13/2003US20030211066 Stable hydroalcoholic compositions
11/13/2003US20030211059 Mixture containing waxes; storage stability; heating, cooling, blending
1 ... 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 ... 2991